Kai Pharms Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for KAI PHARMS INC, and what generic alternatives to KAI PHARMS INC drugs are available?
KAI PHARMS INC has one approved drug.
There are seven US patents protecting KAI PHARMS INC drugs.
There are eighty-five patent family members on KAI PHARMS INC drugs in forty-three countries and seventeen supplementary protection certificates in fifteen countries.
Summary for Kai Pharms Inc
| International Patents: | 85 |
| US Patents: | 7 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Kai Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-002 | Feb 7, 2017 | RX | Yes | Yes | 9,278,995 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-002 | Feb 7, 2017 | RX | Yes | Yes | 11,162,500 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-003 | Feb 7, 2017 | RX | Yes | Yes | 10,344,765 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-003 | Feb 7, 2017 | RX | Yes | Yes | 8,999,932 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-001 | Feb 7, 2017 | RX | Yes | Yes | 9,820,938 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-003 | Feb 7, 2017 | RX | Yes | Yes | 11,162,500 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kai Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Norway | 2017021 | ⤷ Try a Trial |
| South Korea | 20160043954 | ⤷ Try a Trial |
| Mexico | 2015017952 | ⤷ Try a Trial |
| European Patent Office | 2459208 | ⤷ Try a Trial |
| Taiwan | 201116290 | ⤷ Try a Trial |
| South Korea | 20120104513 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Kai Pharms Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2459208 | 132017000041085 | Italy | ⤷ Try a Trial | PRODUCT NAME: ETELCALCETIDE, O UN SUO SALE, COMPRESO ETELCALCETIDE IDROCLORURO(PARSABIV); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/16/1142/001-012, 20161115 |
| 2459208 | CR 2017 00006 | Denmark | ⤷ Try a Trial | PRODUCT NAME: ETELCALCETID ELLER ET SALT DERAF, INKLUSIV ETELCALCETIDHYDROCHLORID; REG. NO/DATE: EU/1/16/1142/001-012 20161115 |
| 2459208 | 654 | Finland | ⤷ Try a Trial | |
| 2459208 | C20170006 00208 | Estonia | ⤷ Try a Trial | PRODUCT NAME: ETELKALTSETIID;REG NO/DATE: EU/1/16/1142 15.11.2016 |
| 2459208 | 17C1009 | France | ⤷ Try a Trial | PRODUCT NAME: ETELCALCETIDE, OU UN SEL DE CELUI-CI, NOTAMMENT LE CHLORHYDRATE D'ETELCALCETIDE; REGISTRATION NO/DATE: EU/1/16/1142/001-012 20161115 |
| 2459208 | 1790012-7 | Sweden | ⤷ Try a Trial | PRODUCT NAME: ETELCALCETIDE, OR SALT THEREOF, INCLUDING ETELCALCETIDE HYDROCHLORIDE; REG. NO/DATE: EU/1/16/1142/001-012 20161115 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
